About Of Xovoltib 50 Mg (Afatinib Dimaleate)

• Xovoltib 50 mg contains Afatinib Dimaleate, a targeted cancer therapy that belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs).
• It is primarily used to treat certain types of non-small cell lung cancer (NSCLC).
• Afatinib blocks specific proteins that promote the growth of cancer cells, particularly in cases where the cancer has mutations in the epidermal growth factor receptor (EGFR) gene.

Uses Of Xovoltib 50 Mg:

• Non-small cell lung cancer (NSCLC): Afatinib is prescribed for patients with NSCLC that is metastatic (has spread) and whose tumors have specific mutations in the EGFR gene. It is usually used as a first-line treatment.

How Xovoltib 50 (Afatinib) Works?

Afatinib works by irreversibly inhibiting the activity of several members of the ErbB family of receptors, including EGFR. These receptors are often overactive or mutated in cancer cells, leading to uncontrolled growth. By blocking their activity, Afatinib helps slow down or stop the growth and spread of cancer cells.